Used primarily in pharmaceutical research as an intermediate in the synthesis of anticonvulsant and neuroprotective agents. Its structural features make it suitable for modulating central nervous system activity, particularly in the development of compounds targeting epilepsy and seizure disorders. The compound's ability to interact with neuronal ion channels and receptors contributes to its potential in creating derivatives with enhanced bioavailability and targeted action. It is also explored in the design of novel hydantoin-based therapeutics for managing neuropathic pain and anxiety-related conditions.